share_log

Piper Sandler Maintains Overweight on Shockwave Medical, Raises Price Target to $360

Benzinga ·  Apr 2 07:57

Piper Sandler analyst Adam Maeder maintains Shockwave Medical (NASDAQ:SWAV) with a Overweight and raises the price target from $290 to $360.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment